Omeros Stock

Omeros EBITDA per Employee

The EBITDA per Employee of Omeros (OMER) as of Aug 8, 2026 is -475,953.49 USD. In the previous year, EBITDA per Employee was -656,038.76 USD — a change of -27.45% (higher).

EBITDA per Employee

-475,953.49USD

YoY

-27.45%

Last updated:

EBITDA per Employee of Omeros is 2026 -475,953.49 USD. EBITDA per Employee of Omeros was 2025 -656,038.76 USD. It decreases by -27.45% higher compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

EBITDA per Employee of Omeros is -475,953.49 USD in 2026.

EBITDA per Employee of Omeros changed from -656,038.76 USD to -475,953.49 USD, representing a -27.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Omeros since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Omeros historically and in real time.

Access this data via the Eulerpool API

Workforce — Omeros

All Key Metrics — Omeros